Immunomodulator compounds
US-2018008554-A1 · Jan 11, 2018 · US
Synthetic analogs of sphingolipids
US8962891B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962891-B2 |
| Application number | US-74204508-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 9, 2008 |
| Priority date | Nov 8, 2007 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides new ceramide analogs indicated as the compounds of formula (II). These novel analogs exhibit a significant anti cancerous effect and are therefore provided as a pharmaceutical composition for treating cell proliferative diseases, neurodegenerative disorders, metabolism-associated conditions, infectious diseases, and immune-related disorders. The invention further provides combined compositions and kits combining the novel ceramide analogs of formula (II) with an additional therapeutic agent.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of a proliferative disorder comprising administering to a subject a therapeutically effective amount of compound of formula (II): wherein X represents a hydrogen atom or OH; Y represents —NHR 6 , wherein R 6 represents a C 2-20 linear or branched alkyl or unsubstituted alkenyl chain or alkenyl chain t…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8962891B2 cover?
- The present invention provides new ceramide analogs indicated as the compounds of formula (II). These novel analogs exhibit a significant anti cancerous effect and are therefore provided as a pharmaceutical composition for treating cell proliferative diseases, neurodegenerative disorders, metabolism-associated conditions, infectious diseases, and immune-related disorders. The invention further …
- Who is the assignee on this patent?
- Dagan Arie, Slavin Shimon, Gatt Shimon, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07C215/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).